Accelerating Alzheimer’s therapeutic development: The past and future of clinical trials
Cell,
Alzheimer’s disease (AD) research has entered a new era with the recent positive phase 3 clinical trials of the anti-Aβ…
Alzheimer’s disease (AD) research has entered a new era with the recent positive phase 3 clinical trials of the anti-Aβ…
The post ESR1 dysfunction triggers neuroinflammation as a critical upstream causative factor of the Alzheimer’s disease process…
A study suggested that PET imaging of tau tangles in the brain could be a way to track development of Alzheimer’s disease…
Alzheimer's disease is a condition characterized by amyloid aggregation, chronic inflammation in brain tissue, and tau…
An accumulation of tau protein -- not amyloid beta -- may be an early sign of Alzheimer's. It could also suggest a treatment.
Brain imaging of pathological tau-protein “tangles” reliably predicts the location of future brain atrophy in Alzheimer’s…
The leading hypothesis on the cause of Alzheimer’s is looking shaky, following a new study that tracked the disease’s early…
Utilizing a recently developed brain imaging technique new research suggests measuring accumulated levels of a protein called…
Brain imaging of pathological tau-protein “tangles” reliably predicts the location of future brain atrophy in Alzheimer’s…
Research suggests tangles of tau could be used to predict how much shrinkage will occur and whereTangles of a protein found…
Brain imaging of pathological tau-protein "tangles" reliably predicts the location of future brain atrophy in Alzheimer's…